Buy a medical business in Poland
22.01.2023
The private healthcare market in Poland is funded by patients’ own funds. In Central and Eastern Europe, it is estimated at 13.9 billion euros per year, and Poland occupies 36% of this European “pie”.
According to CBOS, in 2018, 57% of surveyed residents of Poland used private healthcare services. Most often they turn to private dental services, least often to the services of a private general practitioner and diagnostic laboratories.
Poles are increasingly willing to use the private medical services market. Most often, this is argued by a shorter waiting time for a particular service. In addition, according to the respondents, the best and most dedicated professionals work in the private sector.
Among other reasons for choosing private medical services, CBOS respondents indicate: convenient hours and dates of visits, absence of delays and queues, the level of friendliness of the staff, the level of comfort of treatment, the quality and modernity of medical equipment and a more convenient location.
Packages offered by private healthcare companies usually have the same or similar offerings. An important difference is the price and quantity of individual medical services. However, the possibility of using a specific medical service without a waiting period in itself seems to be the most important argument in favor of purchasing a specific package.
And now some statistics. In 2021, the volume of the private segment of the healthcare services market in Poland increased by 17% compared to the previous year and amounted to PLN 27.7 billion.
The greatest contribution to the growth was made by the so-called FFS expenses (fee-for-service) – payments made by patients immediately after the provision of the service.
According to the forecasts of the research company PMR, in 2022 private medicine will reach PLN 30.5 billion. by volume in terms of money.
“Last year we were dealing with a low 2020 base. In 2022, private healthcare spending could increase by about 10%,” estimates Monika Stefanczyk, director of PMR Pharmaceutical Market Analysis.
Many factors are contributing to this growth, she said, such as demographics (aging and the influx of refugees from Ukraine), as well as increased demand for medical services, the provision of which was postponed in 2020 due to the COVID-19 pandemic.
